ALS Therapy Development Institute Revenue and Competitors
Estimated Revenue & Valuation
- ALS Therapy Development Institute's estimated annual revenue is currently $11.2M per year.
- ALS Therapy Development Institute's estimated revenue per employee is $155,000
Employee Data
- ALS Therapy Development Institute has 72 Employees.
- ALS Therapy Development Institute grew their employee count by 6% last year.
ALS Therapy Development Institute's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, Translational Sciences | Reveal Email/Phone |
2 | Senior Director Pharmacology | Reveal Email/Phone |
3 | Director Cell Biology | Reveal Email/Phone |
4 | Director Events | Reveal Email/Phone |
5 | Director Pharmacology | Reveal Email/Phone |
6 | Director Event and Program Production | Reveal Email/Phone |
7 | Senior Director Development | Reveal Email/Phone |
8 | Senior Director Marketing and Communications | Reveal Email/Phone |
9 | Senior Director Clinical Operations & Executive Administrator to the CEO | Reveal Email/Phone |
10 | Development Director | Reveal Email/Phone |
ALS Therapy Development Institute Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is ALS Therapy Development Institute?
The ALS Therapy Development Institute (http://www.als.net), based in Cambridge, Mass., was founded in 1999 as the ALS Therapy Development Foundation. Re-named in 2006 as a result of its collaboration with the Muscular Dystrophy Association and its Augie's Quest initiative, the Institute continues its mission to discover and develop drugs to treat ALS. A leader in ALS transgenic mouse studies, it excels in identifying novel disease targets, and screening potential treatments for ALS, as well as related neuro muscular disorders such as Alzheimer's, Parkinson's and Huntington diseases.
keywords:N/AN/A
Total Funding
72
Number of Employees
$11.2M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ALS Therapy Development Institute News
In total, she's raised over $750,000. Funds are used to support research efforts at both the ALS Therapy Development Institute and Duke...
Biopharma giant Biogen and RNA-targeted therapy leader Ionis Pharmaceuticals ... pursuit of advancing ALS research and developing therapies.
The ALS Therapy Development Institute (ALS TDI) and its researchers discover and develop potential treatments for ALS. ALS TDI is the...
Microsoft and Team Gleason, the nonprofit organization founded by NFL player Steve Gleason, today launched Project Insight to create an open dataset of facial imagery of people with amyotrophic lateral sclerosis (ALS). The organizations hope to foster innovation in computer vision and broaden th ...
In August, Google AI researchers working with the ALS Therapy Development Institute shared details about Project Euphonia, a speech-to-text transcription service for people with speaking impairments. They showed that, using data sets of audio from both native and non-native English speakers with ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.2M | 72 | -43% | N/A |
#2 | $9.1M | 72 | -21% | N/A |
#3 | $11.2M | 72 | 3% | N/A |
#4 | $9.4M | 72 | 13% | N/A |
#5 | $7.5M | 72 | 33% | N/A |